Core Viewpoint - The F5 class action lawsuit alleges that F5, Inc. and certain executives misled investors regarding the company's revenue outlook and growth potential, while downplaying risks associated with a significant security incident [4][5]. Company Overview - F5, Inc. is a global multi-cloud application security and delivery company that enables customers to deploy, secure, and operate applications both on-premises and via public cloud [3]. Allegations of the Lawsuit - The lawsuit claims that during the Class Period, F5 executives created a false impression of reliable revenue projections and growth, while minimizing risks from seasonality and macroeconomic factors [4]. - It is alleged that F5 was experiencing a significant security incident that jeopardized client security and the company's future prospects [4]. - On October 15, 2025, F5 disclosed a security breach involving a nation-state threat actor, leading to a nearly 14% drop in stock price over two trading days [5]. - Following the breach, on October 27, 2025, F5 reported fourth quarter fiscal year 2025 results that fell significantly below market growth expectations for fiscal 2026, resulting in an additional nearly 11% decline in stock price over two trading days [6]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased F5 securities during the Class Period to seek appointment as lead plaintiff in the lawsuit, representing the interests of all class members [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - The Blue Owl Capital Inc. class action lawsuit alleges that the company and its executives violated the Securities Exchange Act of 1934, with claims centered around undisclosed liquidity issues and significant pressure on its asset base due to BDC redemptions [1][3]. Group 1: Allegations and Financial Performance - The lawsuit claims that Blue Owl failed to disclose meaningful pressure on its asset base from BDC redemptions, leading to undisclosed liquidity issues [3]. - Financial results for Q3 2025 reported fee-related earnings of $376.2 million, missing consensus estimates, and performance revenue fell 33% year over year to $188,000 [4]. - Following the announcement of a merger agreement involving Blue Owl's direct lending businesses, the stock price fell nearly 5% [5]. Group 2: Impact of External Reports - An article published by Financial Times indicated that OBDC II shareholders could face a 20% reduction in investment value due to the merger, which further impacted Blue Owl's stock price, causing a nearly 6% drop [6]. Group 3: Legal Process and Representation - Investors who purchased Blue Owl securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, representing the interests of all class members [7]. - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251 [3]. - Investors have until February 9, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Allegations - Integer designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology devices [4]. - The company allegedly overstated demand for its electrophysiology devices while public assurances contradicted the actual decline in demand and revenue [5]. - On October 23, 2025, Integer lowered its 2025 sales guidance to between $1.840 billion and $1.854 billion, down from a previous range of $1.850 billion to $1.876 billion, which was below analysts' expectations [6]. - Integer projected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026, citing slower adoption of two of its EP devices [6]. Group 3: Stock Impact - Following the announcement of lowered sales guidance, Integer's stock price dropped by $35.22 per share, a decline of over 32%, from $109.11 per share on October 22, 2025, to $73.89 per share on October 23, 2025 [6].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][4]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections" while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

Core Viewpoint - A class action lawsuit has been filed against Fermi Inc. and its executives due to significant stock price drops linked to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as well as claims under Sections 11 and 15 of the Securities Act of 1933 [3]. - Investors have until March 6, 2026, to request to lead the case, which is pending in the U.S. District Court for the Southern District of New York [3]. Group 2: Company Background - Fermi Inc. is an energy and AI infrastructure company aiming to build large-scale nuclear reactors to support grid-independent data centers for AI companies [4]. - The company's flagship project, Project Matador, is designed to provide dedicated power for AI workloads [4]. Group 3: IPO and Allegations - Fermi completed its IPO in October 2025, claiming strong demand for Project Matador and securing a 20-year lease with an investment-grade-rated tenant [5]. - Allegations suggest that Fermi overstated tenant demand and misrepresented the agreement with the First Tenant [6]. Group 4: Stock Price Impact - Following the announcement that the First Tenant terminated the Advance in Aid of Construction Agreement, Fermi's stock dropped by $5.16 per share, over 33%, from $15.25 to $10.09 on December 12, 2025 [7].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance and Stock Impact - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock price drop of $2.18 per share, or 6.9%, from $31.54 to $29.36 [6]. - Following the Q3 2025 results on November 20, 2025, which included further cuts to full-year guidance and acknowledgment that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8%, from $21.04 to $15.82 [7]. Legal Proceedings - Investors have until March 16, 2026, to request to lead the case in the ongoing lawsuit, which is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 in the U.S. District Court for the Southern District of Ohio [3].

Core Viewpoint - Carvana Co. is under investigation for potential violations of federal securities laws due to significant stock price drops linked to claims of accounting improprieties [2][3]. Group 1: Investigation Details - Bleichmar Fonti & Auld LLP is leading the investigation into Carvana for possible securities fraud [1]. - The investigation focuses on whether Carvana overstated its earnings and improperly accounted for related party transactions [3]. Group 2: Stock Performance - Carvana's stock price fell over 20% on January 28, 2026, dropping from $474.06 to a low of $374.55 per share [5]. - The decline was triggered by a report from Gotham City Research LLC, which alleged that Carvana's financial results were significantly affected by undisclosed transactions and debts related to entities controlled by Ernest Garcia II [4]. Group 3: Financial Implications - The Gotham City report claims that hidden relationships within Carvana's financial structure may have overstated earnings by over $1 billion, posing substantial risks to investors [4].

Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding the company's loan delinquency rates and loss mitigation programs during a specified class period [1][3]. Group 1: Class Action Details - Investors in SLM securities from July 25, 2025, to August 14, 2025, can seek appointment as lead plaintiff in the class action lawsuit by February 17, 2026 [1]. - The lawsuit, titled Zappia v. SLM Corporation, accuses SLM and its executives of making false statements and failing to disclose significant increases in early-stage delinquencies [3][4]. Group 2: Allegations and Impact - The lawsuit alleges that SLM overstated the effectiveness of its loss mitigation and loan modification programs, as well as the overall stability of its private education loan delinquency rates [3]. - A report from investment bank TD Cowen indicated that July 2025 delinquencies increased by 49 basis points month-over-month, contradicting SLM's CFO's claims of normal seasonal trends, leading to an approximate 8% drop in SLM's stock price following the report [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who suffered losses during the class period to seek the role of lead plaintiff, representing the interests of all class members [5]. - The lead plaintiff has the authority to select a law firm for the lawsuit and does not need to be the lead plaintiff to share in any potential recovery [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been recognized for its significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [6].

Core Viewpoint - Investors with significant losses in Ramaco Resources, Inc. have until March 31, 2026, to file lead plaintiff applications in a securities class action lawsuit [1] Group 1 - The lawsuit pertains to investors who purchased or acquired Ramaco's securities between July 31, 2025, and October 23, 2025, inclusive [1]

Core Viewpoint - Halper Sadeh LLC is investigating several companies for potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to their sales transactions [1][2]. Group 1: Company Investigations - Stellar Bancorp, Inc. is being investigated regarding its sale to Prosperity Bancshares, Inc. for 0.3803 shares of Prosperity common stock and $11.36 in cash for each share of Stellar common stock [1]. - Gold Resource Corporation's sale to Goldgroup Mining Inc. involves an exchange of 1.4476 common shares of Goldgroup for each share of Gold Resource common stock [2]. - SkyWater Technology, Inc. is under scrutiny for its sale to IonQ, which includes $15.00 in cash and $20.00 in shares of IonQ common stock for each share of SkyWater [2]. Group 2: Legal Rights and Options - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other relief on behalf of shareholders [3]. - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no charge [4].